-
1
-
-
10344230440
-
Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial
-
Carrat F., Bani-Sadr F., Pol S., et al. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA 2004, 292:2839-2848.
-
(2004)
JAMA
, vol.292
, pp. 2839-2848
-
-
Carrat, F.1
Bani-Sadr, F.2
Pol, S.3
-
2
-
-
0035179821
-
The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study
-
Di Martino V., Rufat P., Boyer N., et al. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology 2001, 34:1193-1199.
-
(2001)
Hepatology
, vol.34
, pp. 1193-1199
-
-
Di Martino, V.1
Rufat, P.2
Boyer, N.3
-
3
-
-
0037179698
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
-
Fried M.W., Shiffman M.L., Reddy K.R., et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 2002, 347:975-982.
-
(2002)
N. Engl. J. Med.
, vol.347
, pp. 975-982
-
-
Fried, M.W.1
Shiffman, M.L.2
Reddy, K.R.3
-
4
-
-
79951476165
-
Correlates of high hepatitis C virus RNA load in a cohort of HIV-negative and HIV-positive individuals with haemophilia
-
Gadalla S.M., Preiss L.R., Eyster M.E., et al. Correlates of high hepatitis C virus RNA load in a cohort of HIV-negative and HIV-positive individuals with haemophilia. J. Viral. Hepat. 2011, 18:161-169.
-
(2011)
J. Viral. Hepat.
, vol.18
, pp. 161-169
-
-
Gadalla, S.M.1
Preiss, L.R.2
Eyster, M.E.3
-
5
-
-
84858706070
-
Prediction of response to pegylated interferon plus ribavirin in HIV/ hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations and HCV-RNA load
-
Neukam K., Camacho A., Caruz A., et al. Prediction of response to pegylated interferon plus ribavirin in HIV/ hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations and HCV-RNA load. J. Hepatol. 2012, 56:788-794.
-
(2012)
J. Hepatol.
, vol.56
, pp. 788-794
-
-
Neukam, K.1
Camacho, A.2
Caruz, A.3
-
6
-
-
79952705520
-
HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies
-
Operskalski E.A., Kovacs A. HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies. Curr. HIV/AIDS Rep. 2011, 2011(8):12-22.
-
(2011)
Curr. HIV/AIDS Rep.
, vol.2011
, Issue.8
, pp. 12-22
-
-
Operskalski, E.A.1
Kovacs, A.2
-
7
-
-
36448962362
-
Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients
-
Pineda J.A., Mira J.A., Gil I., et al. Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients. J. Antimicrob. Chemother. 2007, 60:1347-1354.
-
(2007)
J. Antimicrob. Chemother.
, vol.60
, pp. 1347-1354
-
-
Pineda, J.A.1
Mira, J.A.2
Gil, I.3
-
8
-
-
77957825574
-
Variation in interleukin 28B gene predicts response to pegylated interferon plus ribavirin in human immunodeficiency virus/hepatitis C virus-coinfected patients
-
Pineda J.A., Caruz A., Rivero A., et al. Variation in interleukin 28B gene predicts response to pegylated interferon plus ribavirin in human immunodeficiency virus/hepatitis C virus-coinfected patients. Clin. Infect. 2010, 51:788-795.
-
(2010)
Clin. Infect.
, vol.51
, pp. 788-795
-
-
Pineda, J.A.1
Caruz, A.2
Rivero, A.3
-
9
-
-
77956115889
-
Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy
-
Rohrbach J., Robinson N., Harcourt G., et al. Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy. Gut 2010, 59:1252-1258.
-
(2010)
Gut
, vol.59
, pp. 1252-1258
-
-
Rohrbach, J.1
Robinson, N.2
Harcourt, G.3
-
10
-
-
0028838369
-
Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired hepatitis C
-
Sánchez-Quijano A., Andreu J., Gavilán F., et al. Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired hepatitis C. Eur. J. Clin. Microbiol. Infect. Dis. 1995, 14:949-953.
-
(1995)
Eur. J. Clin. Microbiol. Infect. Dis.
, vol.14
, pp. 949-953
-
-
Sánchez-Quijano, A.1
Andreu, J.2
Gavilán, F.3
-
11
-
-
0034031613
-
Determinants of the quantity of hepatitis C virus RNA
-
Thomas D.L., Astemborski J., Vlahov D., et al. Determinants of the quantity of hepatitis C virus RNA. J. Infect. Dis. 2000, 181:844-851.
-
(2000)
J. Infect. Dis.
, vol.181
, pp. 844-851
-
-
Thomas, D.L.1
Astemborski, J.2
Vlahov, D.3
-
12
-
-
3343012408
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients
-
Torriani F.J., Rodriguez-Torres M., Rockstroh J.K., et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N. Engl. J. Med. 2004, 351:438-450.
-
(2004)
N. Engl. J. Med.
, vol.351
, pp. 438-450
-
-
Torriani, F.J.1
Rodriguez-Torres, M.2
Rockstroh, J.K.3
|